Ulpu E.
- Country
- Finland
- Department
- FVR, TURKU CLINIC
Research Overview
- Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
- Evaluation of Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections
- Efficacy, Immunogenicity, and Safety of OVX836 Influenza Vaccine in Preventing RT-PCR-Confirmed Influenza Type A in Healthy Adults Aged 18-59: A Phase 2b Study
Data & Insights
Has run more than one trial at 104 of 363 partner sites.
Specializations
Respiratory Disease Prevention
The investigator specializes in the development and evaluation of vaccines against respiratory syncytial virus (RSV), with particular focus on preventive care for older adults aged 60 and above. Their research encompasses the assessment of humoral immune responses and vaccine effectiveness across different populations.
- RSV vaccine immunogenicity studies
- Long-term immune response monitoring
- Cross-population vaccine effectiveness
Bacterial Disease Prevention
The investigator conducts research on vaccines targeting serious bacterial infections, including work with pneumococcal conjugate vaccines and meningococcal vaccines. Their studies focus on vaccine effectiveness in various age groups, from infants to adults.
- Multi-valent pneumococcal vaccination
- Pentavalent meningococcal prevention
- Pediatric immunization protocols
Viral Disease Management
The investigator's expertise extends to preventing and managing viral infections, particularly focusing on cytomegalovirus (CMV) and herpes zoster. Their research includes innovative approaches to vaccine development and long-term effectiveness studies.
- CMV prevention in young adults
- Herpes zoster vaccine efficacy
- Long-term immunity assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.